HERV-K-derived antigen as a shared tumor antigen for anti-cancer vaccines

摘要

A composition or composition comprising at least one peptide consisting of or containing a shared HERV-K-derived antigen or an expression vector that induces expression of the at least one peptide in vivo, and a pharmaceutically acceptable vehicle or excipient. vaccination. A composition comprising a cytotoxic T lymphocyte (CTL) of a patient treated with such a peptide, or a T cell receptor (TCR) modified T cell that recognizes such a peptide. [Selection diagram] None